期刊文献+

胶质瘤CD133阳性和阴性U87细胞蛋白质组学分析

Proteomics analysis of CD133 + and CD133- cells derived from glioma U87 cells
原文传递
导出
摘要 目的通过对人脑胶质瘤U87细胞中CD133+和CD133一细胞进行配对研究,寻找差异性蛋白。方法通过磁珠选择分离U87中CD133+和CD133-细胞,利用双向凝胶电泳(2D—PAGE)检测上述细胞总体蛋白,分析差异性蛋白点。通过质谱(MALDI—TOF—MS)对蛋白点进行鉴定,建立两种细胞差异性蛋白文库。结果CD133+和CD133一细胞配对比较,蛋白质组学检测结果中,差异有统计学意义(P〈0.05)的2D—PAGE蛋白点共有73个,〉1.5倍差异蛋白点有46个,〉2倍差异蛋白点有27个,〉3倍差异蛋白点有8个。在CD133+U87细胞中,有10个蛋白表达增多(上调),63个蛋白表达下降(下调)。共得到44张高质量质谱肽质量指纹图谱(PMF),鉴定了35种蛋白质。结论CD133+和CD133-细胞是同一细胞株中两种不同的细胞,蛋白方面存在的差异,将成为进一步研究它们相互关系的重要靶点。 Objective To analyze differences between CD133+ and CD133- glioma U87 cells by methods of proteomics. Methods 2D - PAGE was performed to separate the proteins of the CD133 + and CD133- U87 cells, which were isolated by magnetic cell sorting. The differential protein spots were analyzed by software analysis, subject to ingel digestion, and identified by matrix assistant laser desorption timeof - flight mass spectrometry ( MALDI - TOF - MS) and MALDI - TOF/TOF - MS. Results There were 73 differentially expressed protein spots observed in comparing between CD133 + and CD133 - U87 cells by 2D - PAGE ( P 〈 0. 05). Spots with 〉 1.5 - fold expression changes were 46, and 〉 2 - fold were 27, and 〉 3 - fold were 8. Ten spots were increased, while 63 spots were decreased in CD133 + U87 cells. Forty - four high -quality peptide mass fingerprinting and 35 proteins were obtained by MS. Conclusions There are significant differences between CD133 + and CD133- U87 cells. Differentially proteins have been obtained by proteomics analysis, which are important targets to the study of brain cancer stem ceils (BTSCs).
出处 《中华神经外科杂志》 CSCD 北大核心 2012年第5期486-489,共4页 Chinese Journal of Neurosurgery
基金 江苏省自然科学基金(BK2005156) 江苏省卫生厅面上科研项目(H2006040) 镇江市重点医学人才项目志谢:衷心感谢“中国科学院上海生命科学研究院蛋白质组研究分析中心”在“蛋白质组学”研究中所提供的帮助.
关键词 神经胶质瘤 肿瘤干细胞 蛋白质组学 抗原 CD133 Glioma Neoplastic stem cells Proteomics Antigens,CD133
  • 相关文献

参考文献7

  • 1蒲珂,马丽,李少一,刘云会.脑肿瘤干细胞起源的探讨[J].中华神经外科杂志,2010,26(1):91-92. 被引量:5
  • 2黄强,董军,朱玉德,张全斌,季晓燕,王爱东,兰青.人脑胶质瘤组织中分离与培养肿瘤干细胞[J].中华肿瘤杂志,2006,28(5):331-333. 被引量:53
  • 3屠成剑,李辰,丁士健,等.蛋白质组学.见:夏其昌,曾嵘,等主编.蛋白质化学与蛋白质组学.北京:科学出版社,2004:233-339.
  • 4Meregalli M, Farini A, Belicchi M, et al. CD133 ( + ) ceils isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Then 2010, 10:1521-1528.
  • 5Wu Y, Wu PY. CD133 as a marker for cancer stem ceils: pr- ogresses and concerns. Stem Cells Dev,2009, 18:1127-1134.
  • 6李明武,牛朝诗,陈建民,倪永丰,董永飞,高歌,梅加明,傅先明.CD133鉴定胶质瘤干细胞血管周围壁龛的实验研究[J].中华神经医学杂志,2010,9(5):441-445. 被引量:8
  • 7Wan F, Zhang S, Xie R, et al. The utility and limitations of ne- urosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol, 2010, 20 : 877-889.

二级参考文献52

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部